相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations
Julia A. Tree et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion
Guido Papa et al.
PLOS PATHOGENS (2021)
Binding of the SARS-CoV-2 spike protein to glycans
Wei Hao et al.
SCIENCE BULLETIN (2021)
SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells
Yuichiro J. Suzuki et al.
VASCULAR PHARMACOLOGY (2021)
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy
Yash Gupta et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
Ritesh Tandon et al.
JOURNAL OF VIROLOGY (2021)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
The Ocular Surface and the Coronavirus Disease 2019: Does a Dual 'Ocular Route' Exist?
Pietro Emanuele Napoli et al.
JOURNAL OF CLINICAL MEDICINE (2020)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (vol 21, pg 1508, 2015)
Vineet D. Menachery et al.
NATURE MEDICINE (2020)
Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2
Yunjin Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site
Javier A. Jaimes et al.
ISCIENCE (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin
Courtney J. Mycroft-West et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
Qi Zhang et al.
CELL DISCOVERY (2020)
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study
Hin Chu et al.
LANCET MICROBE (2020)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
Adeline Heurich et al.
JOURNAL OF VIROLOGY (2014)
Surfen, a small molecule antagonist of heparan sulfate
Manuela Schuksz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The importance of heparan sulfate in herpesvirus infection
Christopher D. O’Donnell et al.
VIROLOGICA SINICA (2008)
Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling
Yasunori Shintani et al.
EMBO JOURNAL (2006)
Cellular entry of the SARS coronavirus
H Hofmann et al.
TRENDS IN MICROBIOLOGY (2004)
分享论文
